I’m not sure when we’re going to pass the Farm Bill. It could be in the lame duck. It could be next year. It could be the year after. Regardless of who is in the White House or Congress next year, the 2025 congressional agenda complicates the Farm Bill legislative process. The next Congress will likely start by navigating issues such as the debt ceiling, budget reconciliation and executive branch nominations. However, the huge issue will be the five-year expiration of our tax code. The “delta” or difference in terms of the Farm Bill and what we’re debating over is about $10 billion when it comes to reference prices. My understanding is, if Congress does nothing in 2025 on taxes, on Jan. 1, 2026, the tax bill for everyone in this country goes up by $5 trillion. This will be the first big debate of the next Congress and, for the farm economy, it dwarfs any other issue. A reasonable expectation is that this discussion will consume the first half of next year, leaving the Farm Bill debate for the last half of the year, squeezed between the process of approving appropriations bills.
We also have to continue to pay close attention to H5N1. Sometimes when we make investments in animal disease preparedness, we’re not sure if the event will ever actually occur. One of those investments, via the checkoff, we made a while back was in terms of foot and mouth disease, and people said, ‘We haven’t had that in nearly a hundred years, why are we investing in that?’
In reality, this little bit of foresight paid huge dividends this year. When H5N1 hit, we pulled these biosecurity plans off the shelf, we adapted them to this virus, and we plugged them in for a webinar for 1,300 people in this industry, in three days — an unbelievable accomplishment. When we look back to the lessons learned on H5N1, this initial investment, and the subsequent on-farm biosecurity implementation efforts that were a result, made a big difference. We must continue to look around the corner to determine what new investments must be made to ensure we’re ready for the next event, whatever that might be.
On the regulatory side, we’ve been investing in the fight against plant-based beverage mislabeling, and we’ve been proactive on the Dietary Guidelines and other nutrition issues. The team effort with incredible dairy nutrition research coming from the checkoff side, along with numerous industry partnerships along the way has been terrific. We’re going to continue to make our case respectfully, but we are not going to give an inch.
Click here to see more...